CFB
ABMD

Cullen/Frost Bankers’s Abiomed Inc ABMD Stock Holding History

Cullen/Frost Bankers’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-202
Closed -$50K – 1224
2022
Q3 		$50K Buy
202
+2
+1% +$540 ﹤0.01% 701
2022
Q2 		$50K Hold
200
– – ﹤0.01% 706
2022
Q1 		$66K Hold
200
– – ﹤0.01% 691
2021
Q4 		$72K Hold
200
– – ﹤0.01% 685
2021
Q3 		$65K Sell
200
-12
-6% -$4.07K ﹤0.01% 711
2021
Q2 		$66K Buy
212
+12
+6% +$3.68K ﹤0.01% 719
2021
Q1 		$64K Hold
200
– – ﹤0.01% 685
2020
Q4 		$65K Hold
200
– – ﹤0.01% 665
2020
Q3 		$55K Hold
200
– – ﹤0.01% 657
2020
Q2 		$48K Hold
200
– – ﹤0.01% 661
2020
Q1 		$29K Sell
200
-74
-27% -$12.3K ﹤0.01% 586
2019
Q4 		$47K Buy
+274
New +$50.8K ﹤0.01% 603
2019
Q3 		– Sell
-300
Closed -$78K – 1116
2019
Q2 		$78K Hold
300
– – ﹤0.01% 500
2019
Q1 		$86K Buy
+300
New +$99.7K ﹤0.01% 498
2018
Q4 		– Sell
-890
Closed -$400K – 414
2018
Q3 		$400K Sell
890
-148
-14% -$58.3K 0.01% 314
2018
Q2 		$425K Buy
+1,038
New +$376K 0.01% 308

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cullen/Frost Bankers's ABMD Position: Q4 2022 in Review

Cullen/Frost Bankers sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 202 shares — an estimated $50K sold.

Cullen/Frost Bankers first reported a position in ABMD in Q2 2018 and held it in 16 quarters. The position peaked at $425K in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Cullen/Frost Bankers reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Cullen/Frost Bankers sold 202 Abiomed Inc shares in Q4 2022, an estimated $50K.
  • Cullen/Frost Bankers first reported a position in Abiomed Inc in Q2 2018 and held it in 16 quarters.
  • Cullen/Frost Bankers's Abiomed Inc position peaked at $425K in Q2 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Cullen/Frost Bankers's 13F filing for Q4 2022, filed 13 Feb 2023.